Educational Series: Immune Checkpoint Blockade in Treatment of Cancer

This article reviews the biological mechanisms of anti-tumour cellular immunity, with a focus on checkpoint inhibition, and the current status of immune checkpoint blockade in the treatment of cancer. This article is intended as an educational resource for consultants and trainees in medical oncology as well as ancillary healthcare professionals working within the unit of care for cancer patients.

Independent expert commentary provided by Professor Grant McArthur.

Please login below to download this issue (PDF)